The buying from short covering will be a factor in increasing Ampio's share price but the buyers who want to invest will greatly outnumber the buying from the shorts and will be the primary reason for price appreciation.
Spoke to AMPE. The rule is very simple they cannot comment on anything when a trial is in progress. Since you have trials on all three up and running you get no information until trials are complete. It certainly is a game of chicken for the shorts.
Hey racavelli, I saw on one of your posts I believe that you stated that as soon as a partner is announced for Zertane, AMPE will rise to $10. While that's a nice idea, what do you have to back that prediction up? If it makes sense, I may invest some more so I am not chalenging you, just asking.